2-amino-4-methyl-1H-imidazole-5-carboxylic acid hydrate, 95.0%, 1g

(2R,3S)-1-(tert-Butoxycarbonyl)-3-phenylpyrrolidine-2-carboxylic acid, 98%, 10g

Ethyl-6-(4-fluorophenyl)-6-oxohexanoate, 97.0%, 1g

7-Methoxy-2-methyl-3-phenyl-4h-chromen-4-one, 97%, 5g

3-METHOXY-N-(1-METHYLPIPERIDIN-4-YL)-4-((4-((3-OXO-2,3-DIHYDRO-1H-INDEN-4-YL)OXY)-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL)AMINO)BENZAMIDE, 95%, 25mg

1-Bromo-5-fluoro-2-methyl-4-nitrobenzene, 97.0%, 5g

2-(Dimethylamino)-4-methoxythiazole-5-carbaldehyde, 98%, 100mg

2-Ethyloxazolo[5,4-b]pyridine, 98%, 5g

C-[1-(4-Chloro-phenyl)-cyclopentyl]-methylamine, 95.0%, 1g

Flacons à fond rond Verre transparent, 3000 ml, 45/40, 1 Pièce

monoclonal de souris anti-kératine K6, KA12, 0,2 ml

(2S,4S)-tert-Butyl 2-cyano-4-fluoropyrrolidine-1-carboxylate, 95.0%, 5g

1-(2-METHYLPHENYL)CYCLOBUTANE-1-CARBOXYLIC ACID, 95.0%, 250mg